184 related articles for article (PubMed ID: 2369363)
21. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy.
Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640
[TBL] [Abstract][Full Text] [Related]
22. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
[TBL] [Abstract][Full Text] [Related]
23. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
[TBL] [Abstract][Full Text] [Related]
24. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
[TBL] [Abstract][Full Text] [Related]
25. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
[TBL] [Abstract][Full Text] [Related]
26. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
Bredie SJ; Kiemeney LA; de Haan AF; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1996 Apr; 58(4):812-22. PubMed ID: 8644746
[TBL] [Abstract][Full Text] [Related]
27. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
Liu ML; Ylitalo K; Nuotio I; Salonen R; Salonen JT; Taskinen MR
Stroke; 2002 May; 33(5):1255-60. PubMed ID: 11988600
[TBL] [Abstract][Full Text] [Related]
28. Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.
de Graaf J; Swinkels DW; de Haan AF; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1992 Dec; 51(6):1295-310. PubMed ID: 1463012
[TBL] [Abstract][Full Text] [Related]
29. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Cortner JA; Coates PM; Liacouras CA; Jarvik GP
J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
[TBL] [Abstract][Full Text] [Related]
30. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes.
Liu ML; Ylitalo K; Vakkilainen J; Nuotio I; Valkonen M; Lahdenperä S; Viikari J; Taskinen MR
Ann Med; 2002; 34(1):48-54. PubMed ID: 12014434
[TBL] [Abstract][Full Text] [Related]
32. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
[TBL] [Abstract][Full Text] [Related]
33. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
[TBL] [Abstract][Full Text] [Related]
34. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.
Vakkilainen J; Jauhiainen M; Ylitalo K; Nuotio IO; Viikari JS; Ehnholm C; Taskinen MR
J Lipid Res; 2002 Apr; 43(4):598-603. PubMed ID: 11907142
[TBL] [Abstract][Full Text] [Related]
35. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.
Feingold KR; Krauss RM; Pang M; Doerrler W; Jensen P; Grunfeld C
J Clin Endocrinol Metab; 1993 Jun; 76(6):1423-7. PubMed ID: 8501146
[TBL] [Abstract][Full Text] [Related]
36. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
[TBL] [Abstract][Full Text] [Related]
39. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia.
Kwiterovich PO; White S; Forte T; Bachorik PS; Smith H; Sniderman A
Arteriosclerosis; 1987; 7(3):211-25. PubMed ID: 3593067
[TBL] [Abstract][Full Text] [Related]
40. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
